These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6273417)
1. Vipoxin. A protein from Russell's viper venom with high affinity for biogenic amine receptors. Freedman JE; Snyder SH J Biol Chem; 1981 Dec; 256(24):13172-9. PubMed ID: 6273417 [TBL] [Abstract][Full Text] [Related]
2. Dual effects of the snake venom polypeptide vipoxin on receptors for acetylcholine and biogenic amines in Aplysia neurons. Slater NT; Carpenter DO; Freedman JE; Snyder SH Neuroscience; 1985 Feb; 14(2):723-33. PubMed ID: 2986043 [TBL] [Abstract][Full Text] [Related]
3. beta-RTX. A receptor-active protein from Russell's viper (Vipera russelli russelli) venom. Bevan P; Hiestand P J Biol Chem; 1983 Apr; 258(8):5319-26. PubMed ID: 6300128 [TBL] [Abstract][Full Text] [Related]
4. Sequence homology between phospholipase and its inhibitor in snake venom. The primary structure of phospholipase A2 of vipoxin from the venom of the Bulgarian viper (Vipera ammodytes ammodytes, Serpentes). Mancheva I; Kleinschmidt T; Aleksiev B; Braunitzer G Biol Chem Hoppe Seyler; 1987 Apr; 368(4):343-52. PubMed ID: 3606821 [TBL] [Abstract][Full Text] [Related]
5. Two types of Russell's viper revealed by variation in phospholipases A2 from venom of the subspecies. Tsai IH; Lu PJ; Su JC Toxicon; 1996 Jan; 34(1):99-109. PubMed ID: 8835338 [TBL] [Abstract][Full Text] [Related]
6. Sequence homology between phospholipase and its inhibitor in snake venom. The primary structure of the inhibitor of vipoxin from the venom of the Bulgarian viper (Vipera ammodytes ammodytes, Serpentes). Mancheva I; Kleinschmidt T; Aleksiev B; Braunitzer G Hoppe Seylers Z Physiol Chem; 1984 Aug; 365(8):885-94. PubMed ID: 6489936 [TBL] [Abstract][Full Text] [Related]
7. Recognition of Vipera ammodytes meridionalis neurotoxin vipoxin and its components using phage-displayed scFv and polyclonal antivenom sera. Stoyanova V; Aleksandrov R; Lukarska M; Duhalov D; Atanasov V; Petrova S Toxicon; 2012 Oct; 60(5):802-9. PubMed ID: 22750218 [TBL] [Abstract][Full Text] [Related]
8. Vipoxin both activates and antagonizes three types of acetylcholine response in Aplysia neurons. Slater NT; Carpenter DO; Freedman JE; Snyder SH Brain Res; 1983 Nov; 278(1-2):266-70. PubMed ID: 6605785 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic activity and inhibition of the neurotoxic complex vipoxin from the venom of Vipera ammodytes meridionalis. Noetzel C; Chandra V; Perbandt M; Rajashankar K; Singh T; Aleksiev B; Kalkura N; Genov N; Betzel C Z Naturforsch C J Biosci; 2002; 57(11-12):1078-83. PubMed ID: 12562098 [TBL] [Abstract][Full Text] [Related]
10. Crystals of phospholipase A2 inhibitor. The non-toxic component of vipoxin from the venom of Bulgarian viper (Vipera ammodytes). Devedjiev Y; Atanasov B; Mancheva I; Aleksiev B J Mol Biol; 1993 Feb; 229(4):1147-9. PubMed ID: 8445639 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of [3H]nitrendipine binding by phospholipase A2. Goldman ME; Pisano JJ Life Sci; 1985 Oct; 37(14):1301-8. PubMed ID: 2995742 [TBL] [Abstract][Full Text] [Related]
12. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558 [TBL] [Abstract][Full Text] [Related]
13. Purification and partial biochemical characterization of an edema inducing phospholipase A2 from Vipera russelli (Russell's viper) snake venom. Vishwanath BS; Kini RM; Gowda TV Toxicon; 1988; 26(8):713-20. PubMed ID: 3188061 [TBL] [Abstract][Full Text] [Related]
14. Structural and pharmacological comparison of daboiatoxin from Daboia russelli siamensis with viperotoxin F and vipoxin from other vipers. Gopalan G; Thwin MM; Gopalakrishnakone P; Swaminathan K Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):722-9. PubMed ID: 17505111 [TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sites. Mantione CR; Goldman ME; Martin B; Bolger GT; Lueddens HW; Paul SM; Skolnick P Biochem Pharmacol; 1988 Jan; 37(2):339-47. PubMed ID: 2829915 [TBL] [Abstract][Full Text] [Related]
16. Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo. Martin GE; Williams M; Pettibone DJ; Zrada MM; Lotti VJ; Taylor DA; Jones JH J Pharmacol Exp Ther; 1985 May; 233(2):395-401. PubMed ID: 2987478 [TBL] [Abstract][Full Text] [Related]